Skip to main content
  1. Home
  2. Emerging Tech
  3. Features

XPRIZE founder says the future is coming faster than we realize. Here’s why

Add as a preferred source on Google

When you learn about a new or upcoming type of technology, you’ll often realize it’s not just a single, siloed invention. It will rely on breakthroughs in artificial intelligence, material science, and computing power. And when these technologies build upon each other, they start to accelerate the others, say XPRIZE founder Peter H. Diamandis and entrepreneur Steven Kotler in their new book, The Future Is Faster than you Think: How Converging Technologies Are Transforming Business, Industries, and Our Lives.

The duo believes the changes will be profound, and discuss the ways in which virtual reality, 3D-printing, quantum computing, and other technologies will shape industries, governments, and the environment in the near future. Digital Trends spoke with Diamandis and Kotler about the book and these converging technologies.

Thy drugs are quick 

Recommended Videos

There are some industries that require waiting and watching. Pharmaceutical development is one of those — but Diamandis and Kotler say companies such as Insilico Medicine are using A.I. to speed up the often years-long drug discovery process. For these new treatments to work for the general population, clinical trials are still a necessary and lengthy part of the process. In the future, the effect of new drugs could be more effectively modeled with software before such trials, they say. “The hope is that we can model using A.I. and model using quantum computers,” said Diamandis. Lab-created organoids — tissues derived from stem cells that resemble a patient’s liver, heart, and so on — could also help doctors predict how the body will respond to a drug.

Vladimir Nenov/123RF

When medicine is ultra-personalized, a clinical trial won’t necessarily help. Last year, Mila Makovec received a tailor-made treatment for Batten disease, which damages brain cells and leads to blindness and death. It took about a year to create the drug and administer the first dose. “Nothing like that’s ever happened,” said Kotler of the speed at which the Food and Drug Administration approved the treatment. “That’s astounding.” Right now, these types of treatments are prohibitively expensive for most people and require an enormous amount of research. Even with fatal diseases, treatments still need to be tested for safety and efficacy before doctors can treat patients with them.

Fantastic flying machines

In the book, Diamandis and Kotler contend that new transportation options will transform where people live and work. With a combination of autonomous vehicles, Hyperloop, and Uber Elevate, by 2028 you’ll be able to commute from Cleveland, Ohio to a meeting in New York City in about an hour. The book has several of these vignettes, but they won’t necessarily be ubiquitous right away. “The ‘you’ who lives in New York, San Francisco, L.A., etc., is going to get those technologies sooner,” said Kotler. “They’re going to they’re going to show up in places where there’s way more early tech adopters.”

Kitty Hawk's flying protoype
Image used with permission by copyright holder

One aspect that’s missing from the description of the commute is the inevitable growing pains. Your Uber Elevate might pick you up from the roof of a Cleveland skyscraper, but what’s the wait going to be like in the building’s elevators with this new rush of commuters? What kind of pushback will cities get from residents who don’t want a skyport in their backyard? There are also a lot of logistics to consider with the Federal Aviation Association and the U.S. Department of Transportation. “With flying cars, with Hyperloops, with fast development in places like Idaho, we need a sort of nation-wide environmental planning and resource planning, at a level that we’ve never had before,” said Kotler. “The good news is, for the same reasons that we can apply quantum and A.I. to model the human body, we’re starting to be able to model whole ecosystems, which has never really happened before.”

On the ground, the state of the power grid is another problem, especially as cities and states shift to renewable energy. “The only way to really fix it is not to rebuild it,” said Diamandis. “It’s going to be to make it micro grids, independent grids, where it’s just like the internet.” These exist now, but many run on diesel generators and only kick in when the main grid goes down.

Image used with permission by copyright holder

As the population continues to sprawl, it would make sense to do so with a more diversified grid and an eye toward protecting biodiversity. That takes planning and forethought, and it hasn’t happened too often in the U.S. “We know deforestation is a massive, massive, massive problem,” said Kotler, as is soil erosion. “If we’ve got technologies that can solve massive environmental challenges, that certainly seems like a job for governments,” he said.

Addicted to tech

It often seems like technology creates as many problems as it’s poised to solve — like e-waste. Diamandis admits the tradeoff for a personal A.I. that knows your preferences, schedule, and even emotions is a complete depletion of privacy. “I think people are going to end up opting to give their A.I. assistants a lot more access to their daily lives, minute by minute,” he said. That includes access to emails, conversations, and facial expressions that will let your virtual assistant know you’re feeling sad. That way, it will be able to play a cheerful tune when you walk through the door. “I believe that younger people have less of an expectation or a demand for privacy,” said Diamandis. Instead, he believes they favor convenience.

Kotler is a little more hesitant about this all-knowing A.I. He already says smartphones are addictive devices. “I think we’ve sacrificed a generation to our technology, in a sense,” he said. While he thinks we’ve realized it and are trying to fix the problem, it won’t be an instantaneous shift. “With advertising, we talked about in the book, it’s going to get worse, probably, before it gets better,” he said, “but we do think it’s going to get better.” For a lot of these technologies, for early and late adopters alike, it’s probably going to get worse before it gets better.

Jenny McGrath
Former Senior Writer, Home
Jenny McGrath is a senior writer at Digital Trends covering the intersection of tech and the arts and the environment. Before…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more